截止 2025 年 7 月 24 日，本员工持股计划所持有的公司股票已经通过集中竞 一、本员工持股计划的基本情况 公司于 2024 年 1 月 24 日召开第六届董事会第十一次会议，并于 2024 年 2 月 19 日召开 2024 年第一次临时股东大会，均审议通过了《<四川和邦生物科技 股份有限公司第三期员工持股计划（草案）>及其摘要的议案》，具体内容详见公 司在上海证券交易所网站（http://www.sse.com.cn）及指定媒体披露的相关公 告。 2024 年 4 月 25 日，公司收到中国证券登记结算有限责任公司出具的《过户 登记确认书》，确认公司回购专用证券账户所持有的 106,086,829 股公司股票已 于 2024 年 4 月 24 日通过非交易过户至四川和邦生物科技股份有限公司-第三期 员工持股计划账户，公司第三期员工持股计划的锁定期为 12 个月，自公司公告 最后一笔标的股票过户至员工持股计划名下之日起计算，具体内容详见公司在上 海证券交易所网站（http://www.sse.com.cn）及指定媒体披露的相关公告。 二、本员工持股计划股票出售情况及后续安排 证券代码：603077 证 ...

Group 1 - The chemical sector continues to rise, with the chemical ETF (516020) showing a significant opening increase before stabilizing, currently up by 0.3% [1][2] - Key stocks in the sector include Yipuli, which hit the daily limit, and other companies like Hebang Bio and Hongda shares, which rose over 2% and 1% respectively [1][2] - Recent inflows into the chemical ETF indicate strong market interest, with a net subscription of 122 million yuan on July 22 and a total of 146 million yuan over the past five trading days [1][2] Group 2 - The overall profit level in China's chemical industry is currently low, prompting many companies to seek improvements in the competitive landscape, necessitating a new round of supply-side reforms [4] - The supply growth rate in the chemical sector has significantly declined, with institutional holdings at a low point, enhancing market expectations for supply-side reforms [5] - The chemical industry is expected to enter a new long-term prosperity cycle, driven by recent policy changes aimed at boosting economic confidence and improving supply-side conditions [6] Group 3 - The chemical ETF (516020) is currently at a low valuation point, with a price-to-book ratio of 2.08, indicating a favorable time for long-term investment [5] - The potential for industry-wide production cuts and environmental regulations could lead to a significant impact on supply-demand dynamics, particularly for high-concentration chemical products [6]

Investment Rating - The report maintains an "Outperform" rating for the basic chemical industry [2] Core Viewpoints - The basic chemical sector has outperformed the market, with the industry index rising by 1.8% from July 11 to July 18, compared to a 0.7% increase in the Shanghai Composite Index [9][20] - The report highlights significant price increases in TDI, glyphosate, and glufosinate due to supply disruptions and rising demand, particularly in South America [6][31][33] Summary by Sections 1. Core Viewpoints - The basic chemical sector is expected to benefit from supply-side reforms and improved demand due to recent government policies aimed at stabilizing the economy [17] - The report emphasizes the potential for long-term investment in core assets as the profitability of chemical products has likely bottomed out, suggesting a recovery in valuations [17][18] 2. Overall Performance of the Chemical Sector - The basic chemical industry index has shown a year-to-date increase of 10.8%, outperforming both the Shanghai Composite and ChiNext indices by 5.4% and 4.5%, respectively [20][26] 3. Individual Stock Performance in the Chemical Sector - Among 424 stocks in the basic chemical sector, 251 stocks rose while 162 fell during the reporting week, with notable gainers including Shangwei New Materials (+148.8%) and Dongcai Technology (+33.2%) [29][30] 4. Key News and Company Announcements - A fire at Covestro's TDI plant in Germany has led to significant supply disruptions, creating opportunities for price increases in TDI [31][32] - Glyphosate prices have increased to 25,500 CNY per ton, reflecting a 7.16% month-over-month rise, driven by reduced inventory levels [33] - New regulations on glufosinate are expected to constrain supply, potentially leading to price increases as the market adjusts [34]

Core Viewpoint - The Low-E glass concept sector experienced a decline of 0.89%, ranking among the top losers in the market, with significant drops in stocks such as Yamaton and Jinjing Technology [1][2]. Group 1: Market Performance - As of July 18, the Low-E glass concept sector saw a notable decrease, with Yamaton hitting the daily limit down, while other companies like Jinjing Technology and Yaopi Glass also faced substantial declines [1]. - In contrast, four stocks within the sector recorded gains, with Hainan Development leading at an increase of 3.12% [1]. Group 2: Capital Flow - The Low-E glass concept sector experienced a net outflow of 72 million yuan, with eight stocks seeing capital outflows, primarily Yamaton, which had a net outflow of 55.16 million yuan [2]. - Other companies with significant capital outflows included Jinjing Technology and Yaopi Glass, with net outflows of 36.39 million yuan and 12.98 million yuan, respectively [2]. - Conversely, Hainan Development, Beibo Shares, and Hebang Biological were among the stocks with the highest net inflows, attracting 49.97 million yuan, 5.45 million yuan, and 1.49 million yuan, respectively [2].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、获得补助的基本情况 2025 年 7 月 18 日，四川和邦生物科技股份有限公司（以下简称"公司"） 收到与收益相关的政府补助 300 万元、公司全资子公司乐山和邦农业科技有限公 司收到与收益相关的政府补助 1,000 万元，合计金额 1,300 万元，占公司 2024 年度经审计的归属于上市公司股东净利润的 41.32%。 | 证券代码：603077 | 证券简称：和邦生物 | 公告编号：2025-034 | | --- | --- | --- | | 债券代码：113691 | 债券简称：和邦转债 | | 四川和邦生物科技股份有限公司 关于获得政府补助的公告 根据《企业会计准则第 16 号—政府补助》等相关规定，本次政府补助属于 与收益相关的政府补助，将对公司 2025 年度的利润产生积极影响，具体会计处 理及对公司损益的影响最终以会计师年度审计确认后的结果为准，敬请广大投资 者注意投资风险。 特此公告。 四川和邦生物科技股份有限公司董事会 2025 年 7 月 19 日 ...

Core Viewpoint - The company and its wholly-owned subsidiary received a total government subsidy of 13 million yuan, which will positively impact the company's profits for the fiscal year 2025 [1] Group 1: Government Subsidy Details - The company received a subsidy of 3 million yuan, while its subsidiary, Leshan Hebang Agricultural Technology Co., Ltd., received 10 million yuan [1] - The total subsidy represents 41.32% of the company's audited net profit attributable to shareholders for the fiscal year 2024 [1] - The subsidy is classified as a government grant related to income, indicating a direct positive effect on the company's financial performance [1] Group 2: Financial Impact - The subsidy is expected to have a favorable impact on the company's profit for the fiscal year 2025 [1] - The specific accounting treatment and the exact impact on the company's financial results will be confirmed after the annual audit by the accountant [1]

Core Viewpoint - The Low-E glass concept sector experienced a significant decline of 3.55%, with major companies like Yamaton, Sanxia New Material, Jinjing Technology, and Yaopi Glass facing substantial losses [1][2]. Group 1: Market Performance - As of July 15, the Low-E glass concept ranked among the top decliners in the market, with Yamaton hitting the daily limit down [1]. - The sector saw a net outflow of 230 million yuan from main funds, indicating a lack of investor confidence [2]. Group 2: Individual Stock Performance - Yamaton led the outflow with a net withdrawal of 65.6 million yuan, reflecting a drop of 9.99% in its stock price [2]. - Other notable stocks with significant net outflows include Jinjing Technology (34.9 million yuan, down 4.18%) and Yaopi Glass (27.1 million yuan, down 4.03%) [2].

1. Report Industry Investment Rating - Not provided in the doc 2. Core Views 2.1纯碱市场 - 检修带动短期产量偏低但后续将提升，计划内检修较少；国外价格到国内暂无优势，进口窗口未开，国内价格低位出口较好；终端备货充足，需求有回落预期，库存压力难解；市场正反馈情绪回落后维持偏空思路，短期防范风险观望为主 [7][9] 2.2玻璃市场 - 部分前期点火产线等待出品，供应端存政策端利多导向但暂未落地；近周末市场氛围受盘面走强提振，观察梅雨季后市场情绪变化；需求情绪走强库存下行；低位多单持有思路，情绪转弱则灵活离场 [153][155] 3. Summary by Directory 3.1纯碱市场 3.1.1市场综述 - 当期总产量70.89万吨，环比持平，预计后续提升；重质产量40.01万吨，环比增0.43万吨；轻质产量30.88万吨，环比降0.43万吨；进口0.03万吨，环比持平；出口4.1万吨，环比持平；浮法玻璃日熔量158425t/d，环比增650t/d；光伏玻璃日熔量91400t/d，环比降600t/d；重碱消费量33.70万吨，环比增0.02万吨；轻碱表需29.57万吨，环比增0.88万吨；纯碱表需65.50万吨，环比降1.13万吨；碱厂库存186.34万吨，环比增5.39万吨；社会库存23.80万吨，环比增1.00万吨；样本终端原料天数23.36天，环比增1.54天；氨碱法成本1281元，环比持平；氨碱法利润 -81元，环比增40元；联碱法成本1142元，环比降8元；联碱法利润8元，环比增48元；华中重碱 - 轻碱价差0元，环比持平；沙河市场价基差 -75元，环比降48元 [7] 3.1.2月度供需 - 展示了2020 - 2025年各月纯碱当月产量、进口量、表观需求量、出口量数据 [15][17][18][20] 3.1.3基差价差 - 展示了纯碱和玻璃期现货价格对照、纯碱合约基差、跨期价差、玻璃 - 纯碱合约/现货价差数据 [24][25][26][27][29][31][32][34][35][36][38][39][40][41] 3.1.4市场价格 - 沙河区域重质纯碱当期价1207元，环比上周涨23元，环比去年降693元；轻重碱区域价格有不同变化；展示了各区域重质、轻质纯碱价格及价差数据 [44][48][68] 3.1.5供应 - 目前多家企业检修/降负荷，部分企业有计划检修；当期国内纯碱开工率81.32%，环比上周持平，环比去年降6.01%；周产量70.89万吨，环比上周持平，环比去年降1.91%；重质纯碱产量40.01万吨，环比上周增0.43万吨，环比去年降2.47万吨；轻质纯碱产量30.88万吨，环比上周降0.43万吨，环比去年增0.56万吨；重质化率56.44%，环比上周增0.61%，环比去年降1.91%；产销比92.40%，环比上周降1.59%，环比去年降18.59% [74][75] 3.1.6需求 - 展示了浮法、光伏玻璃在产日熔量、重质纯碱日耗量、周度需求、周度表观消费量、产销率及光伏玻璃价格数据 [122][124][126][128][130][131][134][135] 3.1.7库存 - 当期纯碱企业库存186.34万吨，环比增5.39万吨，环比去年增87.98万吨；轻质纯碱企业库存79.13万吨，环比降1.35万吨，环比去年增20.80万吨；重质纯碱企业库存107.21万吨，环比增6.74万吨，环比去年增67.18万吨；库存天数15.45天，环比增0.45天，环比去年增7.19天 [139] 3.1.8仓单数量/有效预报 - Not provided in the doc 3.1.9地产相关数据 - Not provided in the doc 3.2玻璃市场 3.2.1市场综述 - 当期浮法玻璃日熔量158425t/d，环比增650t/d；周产量110.90万吨，环比增0.45万吨；表观消费量120.81万吨，环比增9.71万吨；厂库库存335.51万吨，环比降9.92万吨；天然气线成本1408元，环比增8元；天然气线利润 -178元，环比降8元；煤制气线成本931元，环比增12元；煤制气线利润214元，环比降6元；石油焦线成本1051元，环比增8元；石油焦线利润19元，环比降8元；华东 - 华中价差160元，环比持平；沙河5mm大板基差 -79元，环比降47元 [153] 3.2.2月度供需 - 展示了2020 - 2025年平板玻璃当月产量、浮法玻璃当月进口量、当月产量同比、当月出口量数据 [160][162][163][165] 3.2.3基差价差 - 展示了纯碱和玻璃期现货价格对照、玻璃合约基差、跨期价差、玻璃 - 纯碱合约/现货价差数据 [169][170][171][172][174][175][176][178][180][181][183][184][185][186] 3.2.4市场价格 - 展示了浮法玻璃5mm区域价格，包括沙河、华北、华东等地区不同规格价格及环比情况；还展示了各区域浮法玻璃5mm市场价及沙河、湖北部分企业5mm大板含税价数据 [190][192][193][195][196][198][200][202][204][206][208][210][211][213][215][216][217][219][221][223] 3.2.5供应 - 当期浮法玻璃煤制气企业利润108.78元，环比增22.80元；石油焦企业利润 -50.47元，环比增34.29元；天然气企业利润 -183.11元，环比增5.57元 [227] 3.2.6需求 - Not provided separately in the doc 3.2.7库存 - 厂库库存335.51万吨，环比降9.92万吨，预计后续继续下降 [153]

Core Viewpoint - Sichuan Hebang Biotechnology Co., Ltd. announced the partial release and pledge of shares by its controlling shareholder, Sichuan Hebang Investment Group Co., Ltd., indicating a significant change in the shareholding structure and potential implications for the company's financial stability and investor confidence [1][2][4]. Summary by Sections Share Release Details - Hebang Group released 240,000,000 shares from pledge, accounting for 12.22% of its held shares and 2.72% of the company's total share capital [1][2]. - After the release, the remaining pledged shares amount to 1,069,000,000 shares, which is 54.44% of Hebang Group's total holdings and 12.10% of the company's total share capital [1][2]. Share Pledge Details - The new pledge involves 240,000,000 shares, with the pledge period starting from July 10, 2025, to July 8, 2028, for financing purposes [2][4]. - The pledged shares do not serve as collateral for major asset restructuring or performance compensation [4]. Cumulative Pledge Situation - As of the announcement date, the cumulative pledged shares by Hebang Group and its concerted actor, He Zhenggang, total 1,069,000,000 shares, representing 44.98% of their total holdings and 12.10% of the company's total share capital [1][2][4]. - He Zhenggang holds an additional 412,632,000 shares, which is 4.67% of the company's total share capital [5][6]. Financial Stability and Risk Management - Hebang Group has no shares maturing in the next six months, while 282,000,000 shares are set to mature later, representing 14.36% of their holdings and 3.19% of the company's total share capital, with a corresponding financing balance of 396 million yuan [6]. - The group is expected to manage repayment risks through operational income and dividends, indicating a stable financial outlook [6].

● 四川和邦生物科技股份有限公司（以下简称"公司"）控股股东四川和 邦投资集团有限公司（以下简称"和邦集团"）持有公司的股份数量为 1,963,779,103 股，占公司总股本比例 22.24%。截至本公告披露日，和邦集团累 计质押的股份数量为 1,069,000,000 股，占其持股总数比例为 54.44%，占公司 总股本比例为 12.10%。 ● 和邦集团及其一致行动人贺正刚先生合并持有公司股份总数为 2,376,411,103 股，占公司总股本比例的 26.91%。截至本公告披露日，和邦集团 及其一致行动人贺正刚先生合并质押的股份数量为 1,069,000,000 股，占其持股 总数比例为 44.98%，占公司总股本比例为 12.10%。 | 证券代码：603077 | 证券简称：和邦生物 | 公告编号：2025-033 | | --- | --- | --- | | 债券代码：113691 | 债券简称：和邦转债 | | 四川和邦生物科技股份有限公司关于控股股东 部分股份解除质押及部分股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、 ...